Home  »  Business   »  Lannett Company Inc. (LCI): Worth Noting At $0.71...

Lannett Company Inc. (LCI): Worth Noting At $0.71

Lannett Company Inc. (NYSE:LCI) concluded the trading at $0.71 on Wednesday, November 23 with a rise of 3.89% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $0.68 and 5Y monthly beta was reading 0.96 with its price kept floating in the range of $0.70 and $0.77 on the day. Considering stock’s 52-week price range provides that LCI hit a high price of $2.16 and saw its price falling to a low level of $0.38 during that period. Over a period of past 1-month, stock came adding 58.50% in its value.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


With its current market valuation of $25.78 million, Lannett Company Inc. is set to declare its quarterly results on Feb 01, 2023 – Feb 06, 2023. Analysts are in estimates of -$0.45 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$1.68 for 2023 with estimates of that growing to -$1.33 in next year. These estimates are suggesting current year growth of -11.30% for EPS and 20.80% growth next year.

Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $68.22 million. They suggested that in the process company could generate revenue of as low as $68.2 million which could climb up to $68.24 million to hit a high. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $288.9 million in 2023, which will be -15.20% less from revenue generated by the company last year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review LCI stock’s current outlook then short term indicators are assigning it an average of Hold, while medium term indicators are categorizing the stock at an average of 50% Sell. Long term indicators are suggesting an average of 50% Buy for it.

Digging deeper we become aware of the PEG ratio of the LCI stock which is currently positioned at 0. It further provides that stock’s current price level is 40.41% away from its 20-day simple moving average and is 47.39% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 72.76 while volatility remained at 14.35% over the past week which changes to 8.61% when measuring it over the past month. Beta is valued at 0.91, while measure of average true range or ATR is currently at 0.05.

In comparing Lannett Company Inc. (LCI)’s stock with other industry players reveals that stock’s current price change of 3.89% and that of -56.70% over the past 12 months is in competing position with that of Johnson & Johnson (JNJ) which saw its stock price raised by 0.11% in the last trading and went through an increase of 10.16% in past 12-month trading. Industry’s another major player Pfizer Inc. (PFE) has fall -0.47% down in previous session, but over the past year has faced a fall of -4.37%, while Novartis AG (NVS) was also down -0.47% however its price remained floating in the green at 5.59% over the same period. Lannett Company Inc. has a P/E ratio of 0 against that of Johnson & Johnson’s 24.64 while Pfizer Inc. is showing 9.27 for the same.

Having a second look at Lannett Company Inc. (NYSE:LCI) provides that stock’s average daily trading volume for 3 months was 167.93K, while it jumped to 0.2 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 40.94 million.

The percentage of outstanding shares held by the insiders is 4.30% while it is 39.80% for the institutional holders. The figures also indicate that as of Oct 13, 2022, number of stock’s short shares was 3.96 million which implies a short ratio of 24.69. This shows up a 9.22% of Short Interest in company’s outstanding shares on the day. In October the standing of shares short improved as it was 3.89 million in the previous month. Subtraction of -56.17% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.

Leave a Comment

Your email address will not be published. Required fields are marked *